Trials / Recruiting
RecruitingNCT06127199
Contraceptive Efficacy Study of Ovaprene
A Single Arm, Open-Label Pivotal Contraceptive Efficacy Study of Ovaprene
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 656 (estimated)
- Sponsor
- Daré Bioscience, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability of Ovaprene.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ovaprene | Non-hormonal intravaginal ring |
Timeline
- Start date
- 2023-12-19
- Primary completion
- 2026-06-01
- Completion
- 2026-09-01
- First posted
- 2023-11-13
- Last updated
- 2025-12-17
Locations
27 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06127199. Inclusion in this directory is not an endorsement.